Survival Impact of Adjuvant Chemoradiotherapy in Resected Pancreatic Cancer
Aim: Pancreatic cancer (PC) is one of the most aggressive cancers, with a 5-year survival rate of less than 50% in resectable stages. The aim of this study was to determine the survival effect of adjuvant chemoradiotherapy (CRT) in resected PC. Materials and Methods: We retrospectively analyzed 156...
Saved in:
Main Authors: | Eyyüp ÇAVDAR, Kubilay KARABOYUN, Yakup İRİAĞAÇ, Abdullah SAKİN, Yüksel BEYAZ, Okan AVCI |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayincilik
2025-06-01
|
Series: | Namık Kemal Tıp Dergisi |
Subjects: | |
Online Access: | https://namikkemalmedj.com/articles/survival-impact-of-adjuvant-chemoradiotherapy-in-resected-pancreatic-cancer/doi/nkmj.galenos.2025.81994 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
by: Mao‐Chih Hsieh, et al.
Published: (2018-06-01) -
Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection
by: Elyar Abaydulla, et al.
Published: (2025-12-01) -
Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancer
by: Muharrem Kocar, et al.
Published: (2016-04-01) -
Radiotherapy for cutaneous squamous cell carcinoma: current standards and outlooks
by: A. R. Gevorkov, et al.
Published: (2022-12-01) -
Survival benefit of perioperative chemoradiotherapy in patients with resectable primary gastric adenosquamous carcinoma: a population-based cohort study
by: Di Wu, et al.
Published: (2025-07-01)